Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Phase 1 Study of Asciminib With or Without Sildenafil for Brain Tumors

NCT07039760 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT07039760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Phase 1 Study of Asciminib With or Without Sildenafil for Brain Tumors
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
May 31, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor